PATENT CLAIM ANALYSIS

Application Number: 15742425
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "182000"]

Abstract:
Compounds are provided according to Formula (I): Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 6 , R 7 , R 8 , and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 11):
The compound of  claim 5 , wherein R 2  is hydrogen and R 3  is C 1-6  alkyl.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.59091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15742422', '15660114', '14630889', '14162672', '14785175']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7995501143102781
- 35 USC 102 Novelty (BERT): 0.5315001992519717
- Combined Prediction Score: 0.7727451228044475
- Mean Citation Score: 348.747968
- Max Citation Score: 359.82715
- Similarity Product: 293.133144543919

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test